Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism causes significant psychological distress in women.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Skin symptoms can indicate endocrine disorders and have various treatments.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Insulin resistance may contribute to hair loss in people with androgenic alopecia.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Menopause affects hair and skin; more research needed for treatment.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.